Tenet Q2 Net Income $259M, Adj EPS $2.31; Raises FY 2024 EBITDA, FCF Outlook

TENET HEALTHCARE CORP

2024-Q2 EPS reported $24.22 revenue$10,471,000,000

Q2 net income $259M ($2.64 diluted EPS), up from $123M ($1.15) YoY; adjusted EPS $2.31.
Consolidated Adjusted EBITDA $945M (+12.1% YoY); Ambulatory Care EBITDA $447M (+20.8%).
New $1.5B share repurchase authorization; completed prior $1B program with 4.8M shares bought in H1 2024.
FY 2024 Adjusted EBITDA guidance raised to $3.825-3.975B (+$300M); FCF outlook raised to $1.1-1.35B (+$150M).
Same-hospital admissions up 5.2% vs Q2 2023; same-facility ambulatory surgical cases +0.2% with net rev/case +6.8%.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.